WFA
MLAB icon

Wipfli Financial Advisors’s Mesa Laboratories MLAB Stock Holding History

Wipfli Financial Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Buy
+8
New +$1.46K ﹤0.01% 2451

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Wipfli Financial Advisors's MLAB Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Mesa Laboratories (MLAB) in Q3 2022: 8 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2451 among its holdings.

163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

  • Wipfli Financial Advisors held 8 shares of Mesa Laboratories worth $1K as of Q3 2022.
  • Mesa Laboratories was a new Wipfli Financial Advisors position in Q3 2022.
  • Mesa Laboratories made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2451 holding.
  • 163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.